Fibrinogen and Factor XIII in Venous Thrombosis and Thrombus Stability

Arterioscler Thromb Vasc Biol. 2022 Jun 2:101161ATVBAHA122317164. doi: 10.1161/ATVBAHA.122.317164. Online ahead of print.

ABSTRACT

As the third most common vascular disease, venous thromboembolism is associated with significant mortality and morbidity. Pathogenesis underlying venous thrombosis is still not fully understood. Accumulating data suggest fibrin network structure and factor XIII-mediated crosslinking are major determinants of venous thrombus mass, composition, and stability. Understanding the cellular and molecular mechanisms mediating fibrin(ogen) and factor XIII production and function and their ability to influence venous thrombogenesis and resolution may inspire new anticoagulant strategies that target these proteins to reduce or prevent venous thrombosis in certain at-risk patients. This article summarizes fibrinogen and factor XIII biology and current knowledge of their function during venous thromboembolism.

PMID:35652333 | DOI:10.1161/ATVBAHA.122.317164